Sapience Therapeutics is developing drugs to fight two deadly forms of cancer. Epibone has technology to grow custom bone grafts from a patient’s stem cells. Lumiode specializes in ultra-bright displays for augmented reality and other applications. And Vidrovr has a tool for searching video on the internet.
These are just a few of the innovative startups using research from Columbia’s many laboratories and nurtured by Columbia Technology Ventures, sometimes known as CTV.
“When faculty and graduate students come up with new scientific inventions—therapies, diagnostics, medical devices, robotics, clean energy, cyber security, almost any kind of science done at a university—it’s our role to work with them and help bring those inventions into the market to become products and services that save or improve people’s lives,” said Orin Herskowitz, CTV’s executive director and senior vice president for intellectual property and technology transfer.